x
Visit our new Mobile Website next time you access NetDania with your mobile device

STOKE THERAPEUTICS INC. - COMMON STOCK

12.4100
26-19:59:57 GMT
+0.7200
+6.1591%
Today's Range
11.4900 - 12.4300
ISIN:N/A

Figures - STOKE THERAPEUTICS INC. - COMMON STOCK

Open
11.6000
Close
11.6900
Year Change
135.9320
Year % Change
+135.9320%
52 Week High
16.3999
52 Week Low
3.3500
Volume
896225
Inc. Vol
37278

News - STOKE THERAPEUTICS INC. - COMMON STOCK

29-08:35 GMT
REITs vs. Dividend Stocks: What's a Better Investment?
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:35 GMT
Better Dividend Stock: AT&T vs. Verizon
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:35 GMT
Why This Bitcoin Halving Is Different
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:35 GMT
Here's Exactly How Amazon Stock Could Double Again by 2030
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:35 GMT
Dave Ramsey's Risky Plan For Social Security Is Unrealistic for Most Retirees. Here's Why
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:32 GMT
Real Madrid Team News Vs Bayern Munich: Injury Doubt In Defense
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:32 GMT
Battery EVs Might Not Be The Future Of Transport In China After All
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:26 GMT
FC Barcelona Versus Valencia Preview: Xavi Makes Lineup Changes
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:07 GMT
Tesla Partners With Baidu, Closer To Offering Self-Driving In China
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-08:01 GMT
Major New Dance Prizes Announced By Sadler’s Wells On International Dance Day
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-07:51 GMT
Beware! The Danger of Short-term Setbacks
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-07:32 GMT
Women Climate Leaders Building On A Legacy Spanning 170 Years
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-07:24 GMT
What Factors Will Drive Pfizer's Q1 Performance?
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-07:13 GMT
The Social Security Cost-of-Living Adjustment (COLA) Forecast for 2025 Exposes a Flaw That May Shock Retirees
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-07:00 GMT
How To Take Over A Family Winery In The Hills Of Chianti Rùfina
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:55 GMT
Will A Macau Recovery Drive MGM Stock Higher Following Q1 Results?
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:55 GMT
Up 17% YTD, What To Expect From eBay Q1 Results?
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:55 GMT
A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:55 GMT
What Should You Do With Danaher Stock At $250 After Q1 Beat?
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:55 GMT
Lockheed Martin Stock Will Likely Remain In Focus After A Stellar Q1
Source: NASDAQ Stocks, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:45 GMT
Blackstone Europe: Lyra Bidco, Hipgnosis Agree On Terms Of Recommended Cash Acquisition
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:45 GMT
AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:45 GMT
AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:43 GMT
Billionaire Adani-Backed JV To Raise Up To $1.4 Billion To Bankroll Indian Data Centers
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:20 GMT
Philips Q1 Loss Widens, Backs FY24 Outlook; To Pay $1.1 Bln To Settle Respironics Litigation
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:20 GMT
European Shares Seen Opening Up As Traders Look To Fed Meeting
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:20 GMT
Stockland Reports Strong Commercial Property Operational Metrics In Q3; Backs FY24 Pre-tax FFO View
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-06:10 GMT
Tesla Comes A Step Closer To Self-Driving Approval In China After Deal With Baidu
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-05:56 GMT
The 4 Types Of Generative AI Transforming Our World
Source: Forbes World, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
29-05:54 GMT
Billionaire Bill Ackman Has Almost 20% of His Pershing Square Portfolio Invested in This "Magnificent Seven" Stock
Source: NASDAQ US Markets, Symbol: STOKE THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38336.54
66.18
0.17%
5114.40
11.67
0.23%
17784.15
62.15
0.35%
62500.00
-716
-1.13%
18252.15
7.17
0.04%
38421.10
22.99
0.06%
3113.04
24.4
0.79%
8199.38
29.74
0.36%
17749.06
140.49
0.80%
7644.69
44.9
0.59%
22608.20
188.25
0.84%
2338.71
1.45
0.06%
88.86
-0.439
-0.49%
1.07028
0.00125
0.12%
155.821
-2.472
-1.56%
1.25143
0.00432
0.35%
0.65534
0.00213
0.33%
1.36625
-0.00067
-0.05%
166.74200
-2.521
-1.49%
0.85518
-0.00059
-0.07%
194.99500
-2.372
-1.20%
0.91179
-0.00175
-0.19%
0.97588
-0.00119
-0.12%
0.59606
0.00225
0.38%
105.70000
-0.341
-0.32%
Top Gainers
Name
Last
+/-
%
0.03
0.02
210.00%
0.03
0.01
98.67%
0.13
0.06
85.71%
0.03
0.01
80.72%
1.30
0.58
79.36%
0.15
0.06
69.94%
0.10
0.04
66.11%
0.03
0.01
54.39%
7.35
2.24
43.84%
0.26
0.08
43.73%
Top Losers
Name
Last
+/-
%
5.04
-11.80
-70.06%
0.05
-0.08
-62.96%
0.01
-0.01
-55.14%
0.04
-0.05
-52.38%
1.24
-1.29
-50.99%
0.04
-0.04
-50.00%
0.03
-0.03
-46.25%
0.17
-0.12
-41.94%
0.08
-0.06
-39.29%
0.02
-0.01
-34.60%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy